EGFR [5,100,101,102,103], c-Kit (also known as CD117) [5,17,102] and vascular endothelial growth factor (VEGF) [104,105] are candidate biomarkers of basal-like breast cancer with targeted therapies in development. The gene discussed is KIT; the disease is breast carcinoma.